Bingchen Han, PhD
Dr. Han earned his PhD in cancer biology from the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences in Beijing, China.
Yanli Jin, PhD
Dr. Jin earned her PhD in cancer biology from Zhongshan School of Medicine, Sun Yat-sen University in Guangzhou, China.
Tilley Jenkins Vogel, MD
Tilley Jenkins attended medical school at The University of North Carolina at Chapel Hill. She thereafter completed a residency in Obstetrics and Gynecology at The University of Washington Medical Center in Seattle. She is currently a clinical and research fellow in Gynecologic Oncology at Cedars-Sinai/UCLA Medical Centers. At present she is working in the Women's Cancer Program laboratory at the Samuel Oschin Cancer Center under the direction of Xiaojiang Cui, PhD investigating the role of FOXC1 in ovarian cancer metastasis and invasion.
Ying Qu, MD, PhD
Ying Qu, MD, PhD, attended medical school at Shanghai JiaoTong University in China. She finished her PhD program at Shanghai JiaoTong University medical school. She was trained at John Wayne Cancer Institute in Santa Monica on breast cancer translational research. She is currently a postdoctoral fellow in Gynecologic Oncology at Cedars-Sinai/UCLA Medical Centers. At present, she is working in the Women's Cancer Program laboratory at the Samuel Oschin Cancer Center under the direction of Xiaojiang Cui, PhD, investigating the role of TXNL2 in regulating breast cancer malignancy and stem cell property.
Shin Saito, MD
Visiting Postdoc Scientist
Shin Saito, MD, attended Asahikawa Medical University in Japan. He completed a residency in surgery at Jichi Medical University in Japan. After attending graduate school at Jichi Medical University, he joined Cedars-Sinai Medical Center. At present, he is working in the Women's Cancer Program laboratory under the direction of Harmik Soukiasian, MD and Xiaojiang Cui, PhD, investigating the role of FOXC1 in lung cancer and/or breast cancers progression
Michael Choi, MD
Resident, Department of Surgery
Michael Choi received his Bachelor of Science degree from Stanford University where he also performed research in the Department of Neurosurgery investigating the mechanisms of synaptogenesis after stroke. He later received his medical degree from The University of Chicago. He is currently a third-year resident in the Department of General Surgery at Cedars-Sinai Medical Center. At present, he is working in the Women's Cancer Program laboratory under the direction of Xiaojiang Cui, PhD investigating the role of FOXC1 in BRCA mutant breast cancer as well as the mechanism of herceptin-resistance in basal-like breast cancers.
Emi Suzuki graduated from University of California, Santa Barbara with a degree in Biological Sciences. She is a research associate for cell culture and molecular research fields in Dr. Xiaojiang Cui’s lab within the Women’s Cancer Program.